Biogen Inc. (BIIB) Social Stream



Biogen Inc. (BIIB): $217.81

0.25 (-0.11%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add BIIB to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#80 of 360

in industry

BIOGEN INC (BIIB) Price Targets From Analysts

Use the tables below to see what analysts covering BIOGEN INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-28 27 $502 $259 $368.074 $260.28 41.41%
2021-11-19 27 $502 $209 $364.321 $260.28 39.97%
2021-11-30 27 $502 $209 $362.607 $260.28 39.31%
2021-12-08 27 $502 $209 $359.448 $260.28 38.1%
2021-12-09 28 $502 $209 $355.8 $260.28 36.7%
2021-12-21 28 $502 $209 $352.344 $260.28 35.37%
2021-12-22 28 $502 $209 $341.466 $260.28 31.19%
2021-12-23 28 $502 $209 $340.133 $260.28 30.68%
2022-01-07 28 $500 $209 $332.266 $260.28 27.66%
2022-01-13 29 $500 $195 $316.548 $260.28 21.62%
2022-01-14 29 $500 $195 $315.58 $260.28 21.25%
2022-01-18 29 $500 $195 $309.709 $260.28 18.99%
2022-01-28 30 $500 $195 $305.129 $260.28 17.23%
2022-02-02 29 $500 $195 $305.129 $260.28 17.23%
2022-02-04 30 $500 $185 $299.483 $260.28 15.06%
2022-02-08 30 $500 $185 $287.1 $260.28 10.3%
2022-02-15 30 $500 $185 $286.333 $260.28 10.01%
2022-02-25 30 $500 $185 $286.066 $260.28 9.91%
2022-03-03 30 $500 $185 $286.766 $260.28 10.18%
2022-03-08 30 $500 $185 $284.066 $260.28 9.14%
2022-03-11 30 $500 $185 $284.3 $260.28 9.23%
2022-03-28 30 $500 $185 $284.133 $260.28 9.16%
2022-03-31 29 $500 $185 $287 $260.28 10.27%
2022-04-08 29 $500 $185 $283.448 $260.28 8.9%
2022-04-12 28 $500 $185 $278.034 $260.28 6.82%
2022-04-18 28 $440 $185 $273.555 $260.28 5.1%
2022-04-22 28 $440 $185 $272.52 $260.28 4.7%
2022-04-26 27 $440 $185 $272.52 $260.28 4.7%
2022-05-03 28 $440 $188 $272.624 $260.28 4.74%
2022-05-05 28 $440 $185 $271.175 $260.28 4.19%
2022-05-09 28 $440 $185 $269.396 $260.28 3.5%
2022-06-01 28 $440 $185 $271.182 $260.28 4.19%
2022-06-14 22 $423 $185 $257.35 $260.28 -1.13%
2022-07-22 24 $350 $183 $247.444 $260.28 -4.93%
2022-08-13 22 $350 $183 $247.764 $260.28 -4.81%
2022-09-17 22 $350 $183 $247.484 $260.28 -4.92%
2022-09-26 22 $350 $183 $247.284 $260.28 -4.99%
2022-09-28 24 $360 $200 $256.044 $260.28 -1.63%
2022-09-30 24 $360 $200 $273.364 $260.28 5.03%
2022-10-06 25 $360 $200 $277.764 $260.28 6.72%
2022-10-07 25 $360 $202 $280.764 $260.28 7.87%
2022-10-24 25 $360 $202 $284.004 $260.28 9.11%
2022-10-26 26 $360 $202 $287.754 $260.28 10.56%
2022-10-27 27 $370 $202 $294.244 $260.28 13.05%
2022-11-01 27 $370 $202 $293.503 $260.28 12.76%
2022-11-11 27 $370 $215.1 $296.119 $260.28 13.77%
2022-11-15 27 $370 $215.1 $301.196 $260.28 15.72%
2022-11-21 27 $370 $215.1 $302.157 $260.28 16.09%
2022-11-30 27 $370 $215.1 $303.273 $260.28 16.52%
2022-12-16 27 $370 $215.1 $309.542 $260.28 18.93%
2023-01-09 27 $370 $215.1 $308.58 $260.28 18.56%
2023-01-23 27 $370 $215.1 $308.85 $260.28 18.66%
2023-01-24 27 $370 $215.1 $309.619 $260.28 18.96%
2023-01-27 27 $370 $217 $317.52 $260.28 21.99%
2023-02-09 27 $370 $249 $321.708 $260.28 23.6%
2023-02-16 27 $370 $249 $322.166 $260.28 23.78%
2023-03-14 27 $370 $249 $323.083 $260.28 24.13%
2023-03-31 27 $370 $249 $322.791 $260.28 24.02%
2023-04-05 27 $370 $249 $322.375 $260.28 23.86%
2023-04-12 27 $370 $249 $321.791 $260.28 23.63%
2023-04-17 27 $370 $263 $322.375 $260.28 23.86%
2023-04-20 27 $370 $263 $325.125 $260.28 24.91%
2023-04-21 27 $370 $263 $325.333 $260.28 24.99%
2023-04-26 27 $370 $263 $325.166 $260.28 24.93%
2023-04-27 27 $371 $263 $326.041 $260.28 25.27%
2023-05-01 27 $371 $263 $329.375 $260.28 26.55%
2023-05-02 27 $371 $263 $330.416 $260.28 26.95%
2023-05-03 27 $371 $263 $331.25 $260.28 27.27%
2023-05-04 27 $371 $263 $332.291 $260.28 27.67%
2023-05-22 28 $371 $263 $331.521 $260.28 27.37%
2023-06-07 28 $371 $263 $332.041 $260.28 27.57%
2023-06-12 27 $371 $263 $332.458 $260.28 27.73%
2023-07-07 27 $371 $263 $333.291 $260.28 28.05%
2023-07-10 27 $371 $269 $333.541 $260.28 28.15%
2023-07-12 27 $370 $269 $332.541 $260.28 27.76%
2023-07-17 27 $370 $269 $332.916 $260.28 27.91%
2023-07-24 27 $370 $269 $331.5 $260.28 27.36%
2023-07-26 27 $370 $268 $333.708 $260.28 28.21%
2023-07-30 27 $379 $268 $335.583 $260.28 28.93%
2023-07-31 27 $380 $276 $336.541 $260.28 29.3%
2023-08-07 27 $380 $269 $336.25 $260.28 29.19%
2023-08-08 27 $370 $269 $327.875 $260.28 25.97%
2023-08-09 27 $370 $269 $327.583 $260.28 25.86%
2023-08-14 27 $370 $269 $326.958 $260.28 25.62%
2023-08-29 28 $370 $269 $326.16 $260.28 25.31%
2023-10-08 28 $381 $269 $328.153 $260.28 26.08%
2023-10-13 28 $370 $269 $327.384 $260.28 25.78%
2023-10-23 28 $370 $270 $327.423 $260.28 25.8%
2023-10-25 28 $370 $270 $327.192 $260.28 25.71%
2023-10-31 28 $365 $266 $325.32 $260.28 24.99%
2023-11-10 28 $373 $239 $322.08 $260.28 23.74%
2023-11-27 29 $373 $239 $319.68 $260.28 22.82%
2023-12-07 29 $373 $239 $316.346 $260.28 21.54%
2023-12-12 29 $364 $239 $316 $260.28 21.41%
2023-12-14 29 $364 $239 $314.923 $260.28 20.99%
2023-12-18 30 $364 $239 $315.5 $260.28 21.22%
2023-12-20 30 $364 $239 $315.333 $260.28 21.15%
2023-12-22 30 $364 $239 $313.481 $260.28 20.44%

The Trend in the Analyst Price Target


BIIB's average price target has moved down $16.5 over the prior 31 weeks.

Over the past 50 weeks, BIIB's average upside potential has been 19.7%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-16 27 370 249 322.166 271.53 18.65%
2023-04-12 27 370 249 321.791 285.79 12.6%
2023-05-03 27 371 263 331.250 311.00 6.51%
2023-07-31 27 380 276 336.541 270.19 24.56%
2023-10-31 28 365 266 325.320 237.54 36.95%

BIIB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.45 21 3 5 0 0 29

The Trend in the Broker Recommendations


BIIB's average broker recommendation rating improved by 0.59 over the prior 20 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, BIOGEN INC's number of analysts covering the stock is greater than 11961.66% of them.
  • In terms of how BIOGEN INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 11831.3% of that group.
  • BIOGEN INC's upside potential (average analyst target price relative to current price) is greater than 2668.38% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, BIOGEN INC's variance in analysts' estimates is lower than -7230.72% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BIOGEN INC are AMGN, TAK, and GSK.

Make investment decisions regarding BIIB using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!